Literature DB >> 1493843

Acetylator phenotypes of Jordanian diabetics.

Y Irshaid1, H al-Hadidi, M Abuirjeie, A Latif, O Sartawi, N Rawashdeh.   

Abstract

The acetylator phenotype was determined in 31 insulin-dependent (IDDM) and 110 noninsulin-dependent (NIDDM) Jordanian diabetics, and was compared to that of 160 healthy volunteers of the same ethnic group. Dapsone was used as the test drug. The rapid acetylator phenotype was slightly less frequent in IDDM and slightly more frequent in NIDDM. Neither of the differences was significant. When acetylator status in the two types of diabetes mellitus was compared, there was a significant difference among the two groups. Patients with IDDM had a higher percentage of the slow acetylator phenotype when compared to NIDDM patients. The association between acetylator status and IDDM in Jordanians, which agrees with that reported for the Saudi Arabian population, is the reverse of what is found in European populations. The results demonstrate ethnic differences in acetylator status among IDDM patients.

Entities:  

Mesh:

Year:  1992        PMID: 1493843     DOI: 10.1007/bf02284960

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Genetic control of isoniazid metabolism in man.

Authors:  D A EVANS; K A MANLEY; V A McKUSICK
Journal:  Br Med J       Date:  1960-08-13

2.  Confidence intervals rather than P values: estimation rather than hypothesis testing.

Authors:  M J Gardner; D G Altman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

3.  The effect of glucose on acetylation status.

Authors:  D Suhardjono; J Boutagy; G M Shenfield
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

4.  Acetylator phenotypes and type I (insulin-dependent) diabetics with microvascular disease.

Authors:  H J Bodansky; P L Drury; A G Cudworth; D A Evans
Journal:  Diabetes       Date:  1981-11       Impact factor: 9.461

5.  N-acetylation in healthy and diseased children.

Authors:  E Hadasová; V Brysová; E Kadlcáková
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Hepatic acetylator phenotype in diabetes mellitus.

Authors:  J M Ladero; A Arrojo; R E de Salamanca; M Gomez; F Cano; M Alfonso
Journal:  Ann Clin Res       Date:  1982-08

7.  Acetylator status and diabetic neuropathy.

Authors:  G M Shenfield; V J McCann; R Tjokresetio
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

Review 8.  Acetylator genotype and arylamine-induced carcinogenesis.

Authors:  D W Hein
Journal:  Biochim Biophys Acta       Date:  1988-08-03

9.  Acetylator phenotypes in diabetes mellitus.

Authors:  D Stryjek-Kamińska; B Malczewski; A Kopeć; K Rowińska-Marcińska
Journal:  Acta Diabetol Lat       Date:  1988 Jan-Mar

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  2 in total

1.  Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.

Authors:  Etienne Patin; Luis B Barreiro; Pardis C Sabeti; Frédéric Austerlitz; Francesca Luca; Antti Sajantila; Doron M Behar; Ornella Semino; Anavaj Sakuntabhai; Nicole Guiso; Brigitte Gicquel; Ken McElreavey; Rosalind M Harding; Evelyne Heyer; Lluis Quintana-Murci
Journal:  Am J Hum Genet       Date:  2006-01-13       Impact factor: 11.025

2.  Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice.

Authors:  Yazun Bashir Jarrar; Luay Al-Essa; Abdulhasib Kilani; Mariam Hasan; Walid Al-Qerem
Journal:  Diabetes Metab Syndr Obes       Date:  2018-09-25       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.